• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

近红外荧光成像吲哚菁绿预测下肢动脉疾病血运重建后的临床转归。

Near-Infrared Fluorescence Imaging With Indocyanine Green to Predict Clinical Outcome After Revascularization in Lower Extremity Arterial Disease.

机构信息

Department of Surgery, Leiden University Medical Center, The Netherlands.

Department of Interventional Radiology, Leiden University Medical Center, The Netherlands.

出版信息

Angiology. 2024 Oct;75(9):884-892. doi: 10.1177/00033197231186096. Epub 2023 Jun 26.

DOI:10.1177/00033197231186096
PMID:37358400
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11375904/
Abstract

Contemporary quality control methods are often insufficient in predicting clinical outcomes after revascularization in lower extremity arterial disease (LEAD) patients. This study evaluates the potential of near-infrared fluorescence imaging with indocyanine green to predict the clinical outcome following revascularization. Near-infrared fluorescence imaging was performed before and within 5 days following the revascularization procedure. Clinical improvement was defined as substantial improvement of pain free walking distance, reduction of rest- and/or nocturnal pain, or tendency toward wound healing. Time-intensity curves and 8 perfusion parameters were extracted from the dorsum of the treated foot. The quantified postinterventional perfusion improvement was compared within the clinical outcome groups. Successful near-infrared fluorescence imaging was performed in 72 patients (76 limbs, 52.6% claudication, 47.4% chronic limb-threatening ischemia) including 40 endovascular- and 36 surgical/hybrid revascularizations. Clinical improvement was observed in 61 patients. All perfusion parameters showed a significant postinterventional difference in the clinical improvement group (-values <.001), while no significant differences were seen in the group without clinical improvement (-values .168-.929). Four parameters demonstrated significant differences in percentage improvement comparing the outcome groups (-values within .002-.006). Near-infrared fluorescence imaging has promising additional value besides clinical parameters for predicting the clinical outcome of revascularized LEAD patients.

摘要

当代的质量控制方法往往不足以预测下肢动脉疾病(LEAD)患者血运重建后的临床结果。本研究评估了吲哚菁绿近红外荧光成像预测血运重建后临床结果的潜力。近红外荧光成像在血运重建术前后 5 天内进行。临床改善定义为无痛行走距离的显著改善、休息时和/或夜间疼痛的减轻或伤口愈合的趋势。从治疗足部的背面提取时间-强度曲线和 8 个灌注参数。在临床结果组内比较了定量的介入后灌注改善情况。在 72 名患者(76 条肢体,52.6%跛行,47.4%慢性肢体威胁性缺血)中成功进行了近红外荧光成像,包括 40 例血管内和 36 例手术/杂交血运重建。61 名患者观察到临床改善。在临床改善组中,所有灌注参数在介入后均显示出显著差异(-值<.001),而在无临床改善组中则未观察到显著差异(-值.168-.929)。与临床结果组相比,有四个参数在百分比改善方面显示出显著差异(-值在.002-.006 之间)。近红外荧光成像除了临床参数外,对预测血运重建的 LEAD 患者的临床结果具有有前景的附加价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c699/11375904/24d5cc90a2f8/10.1177_00033197231186096-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c699/11375904/0c78a64b383a/10.1177_00033197231186096-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c699/11375904/059978532026/10.1177_00033197231186096-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c699/11375904/24d5cc90a2f8/10.1177_00033197231186096-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c699/11375904/0c78a64b383a/10.1177_00033197231186096-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c699/11375904/059978532026/10.1177_00033197231186096-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c699/11375904/24d5cc90a2f8/10.1177_00033197231186096-fig3.jpg

相似文献

1
Near-Infrared Fluorescence Imaging With Indocyanine Green to Predict Clinical Outcome After Revascularization in Lower Extremity Arterial Disease.近红外荧光成像吲哚菁绿预测下肢动脉疾病血运重建后的临床转归。
Angiology. 2024 Oct;75(9):884-892. doi: 10.1177/00033197231186096. Epub 2023 Jun 26.
2
Assessment of Tissue Viability Following Amputation Surgery Using Near-Infrared Fluorescence Imaging With Indocyanine Green.应用近红外荧光成像技术联合吲哚菁绿评估断肢再植术后组织活力
Ann Vasc Surg. 2022 Jan;78:281-287. doi: 10.1016/j.avsg.2021.04.030. Epub 2021 Jun 25.
3
Evaluation of the Angiosome Concept Using Near-Infrared Fluorescence Imaging with Indocyanine Green.应用近红外荧光成像技术联合吲哚菁绿评估血管生成体概念。
Ann Vasc Surg. 2023 Jul;93:283-290. doi: 10.1016/j.avsg.2023.01.006. Epub 2023 Jan 13.
4
SPY technology as an adjunctive measure for lower extremity perfusion.SPY技术作为下肢灌注的辅助措施。
J Vasc Surg. 2016 Jul;64(1):195-201. doi: 10.1016/j.jvs.2016.01.039. Epub 2016 Mar 16.
5
Maximal Systolic Acceleration and Near-Infrared Fluorescence Imaging With Indocyanine Green as Predictors for Successful Lower Extremity Revascularization.以最大收缩期加速度和吲哚菁绿近红外荧光成像作为下肢血管重建成功的预测指标
J Endovasc Ther. 2024 Sep 5:15266028241274568. doi: 10.1177/15266028241274568.
6
Outcomes of open and endovascular lower extremity revascularization in active smokers with advanced peripheral arterial disease.患有晚期外周动脉疾病的活跃吸烟者进行开放性和血管腔内下肢血管重建术的结果。
J Vasc Surg. 2017 Jun;65(6):1680-1689. doi: 10.1016/j.jvs.2017.01.025.
7
Near-infrared fluorescence imaging with indocyanine green for quantification of changes in tissue perfusion following revascularization.近红外荧光成像联合吲哚菁绿用于定量评估血运重建后组织灌注的变化。
Vascular. 2022 Oct;30(5):867-873. doi: 10.1177/17085381211032826. Epub 2021 Jul 28.
8
In Patients with Severe Peripheral Arterial Disease, Revascularization-Induced Improvement in Lower Extremity Ischemia Can Be Detected by Laser Speckle Contrast Imaging of the Fluctuation in Blood Perfusion after Local Heating.在严重外周动脉疾病患者中,局部加热后通过激光散斑对比成像检测血流灌注波动,可发现血运重建诱导的下肢缺血改善情况。
Ann Vasc Surg. 2018 Apr;48:67-74. doi: 10.1016/j.avsg.2017.09.022. Epub 2017 Dec 5.
9
Major adverse limb events and major adverse cardiac events after contemporary lower extremity bypass and infrainguinal endovascular intervention in patients with claudication.间歇性跛行患者接受当代下肢旁路手术和股动脉以下血管腔内介入治疗后的主要肢体不良事件和主要心脏不良事件
J Vasc Surg. 2018 Dec;68(6):1817-1823. doi: 10.1016/j.jvs.2018.06.193.
10
Perfusion increase in foot angiosomes: Comparison between direct and indirect revascularization of crural arteries.足部动脉分布区的灌注增加:直接和间接重建小腿动脉的比较。
Scand J Surg. 2024 Jun;113(2):174-181. doi: 10.1177/14574969241242205. Epub 2024 Jun 2.

引用本文的文献

1
Assessment of Hard-To-Heal Lower Leg Wounds With Near-Infrared Fluorescent Imaging: A Pilot Cohort Study.近红外荧光成像评估难愈合小腿伤口:一项前瞻性队列研究
Int Wound J. 2025 Jul;22(7):e70723. doi: 10.1111/iwj.70723.
2
Quantitative intra-arterial fluorescence angiography for direct monitoring of peripheral revascularization effects.定量动脉内荧光血管造影术用于直接监测外周血管重建效果。
J Vasc Surg Cases Innov Tech. 2025 Mar 4;11(3):101770. doi: 10.1016/j.jvscit.2025.101770. eCollection 2025 Jun.
3
Indocyanine Green Fluorescence Angiography to Assess Tissue Perfusion Before Common Femoral Artery Aneurysm Ligation After Transfemoral Amputation.

本文引用的文献

1
Normalization of Time-Intensity Curves for Quantification of Foot Perfusion Using Near-Infrared Fluorescence Imaging With Indocyanine Green.应用近红外荧光成像吲哚菁绿技术对足部灌注进行定量分析的时间-强度曲线的标准化。
J Endovasc Ther. 2023 Jun;30(3):364-371. doi: 10.1177/15266028221081085. Epub 2022 Mar 3.
2
Evaluation of Hyperspectral Imaging for Follow-Up Assessment after Revascularization in Peripheral Artery Disease.外周动脉疾病血运重建术后随访评估的高光谱成像技术评估
J Clin Med. 2022 Jan 30;11(3):758. doi: 10.3390/jcm11030758.
3
Near-infrared fluorescence imaging with indocyanine green for quantification of changes in tissue perfusion following revascularization.
吲哚菁绿荧光血管造影术用于评估经股截肢术后股总动脉瘤结扎前的组织灌注情况。
EJVES Vasc Forum. 2025 Jan 27;63:41-44. doi: 10.1016/j.ejvsvf.2025.01.003. eCollection 2025.
4
Establishing reference curves for vital tissue perfusion using quantitative near-infrared fluorescence imaging with indocyanine green.使用吲哚菁绿定量近红外荧光成像建立重要组织灌注的参考曲线。
Langenbecks Arch Surg. 2025 Jan 8;410(1):28. doi: 10.1007/s00423-024-03589-1.
5
Case Report: The application of novel imaging technologies in lower extremity peripheral artery disease: NIR-II imaging, OCTA, and LSFG.病例报告:新型成像技术在下肢外周动脉疾病中的应用:近红外二区成像、光学相干断层扫描血管造影和激光散斑血流成像
Front Cardiovasc Med. 2024 Sep 18;11:1460708. doi: 10.3389/fcvm.2024.1460708. eCollection 2024.
近红外荧光成像联合吲哚菁绿用于定量评估血运重建后组织灌注的变化。
Vascular. 2022 Oct;30(5):867-873. doi: 10.1177/17085381211032826. Epub 2021 Jul 28.
4
Lower Extremity Peripheral Artery Disease: Contemporary Epidemiology, Management Gaps, and Future Directions: A Scientific Statement From the American Heart Association.下肢外周动脉疾病:当代流行病学、管理差距与未来方向:美国心脏协会科学声明。
Circulation. 2021 Aug 31;144(9):e171-e191. doi: 10.1161/CIR.0000000000001005. Epub 2021 Jul 28.
5
Long-term outcomes following endovascular and surgical revascularization for peripheral artery disease: a propensity score-matched analysis.腔内治疗和手术血运重建治疗外周动脉疾病的长期结果:倾向评分匹配分析。
Eur Heart J. 2021 Dec 28;43(1):32-40. doi: 10.1093/eurheartj/ehab116.
6
SPECT/CT Imaging: A Noninvasive Approach for Evaluating Serial Changes in Angiosome Foot Perfusion in Critical Limb Ischemia.SPECT/CT 成像:一种评估临界肢体缺血性疾病的血管体足部灌注的连续变化的非侵入性方法。
Adv Wound Care (New Rochelle). 2020 Mar 1;9(3):103-110. doi: 10.1089/wound.2018.0924. Epub 2020 Jan 24.
7
Clinical impact of improvement in the ankle-brachial index after endovascular therapy for peripheral arterial disease.外周动脉疾病血管内治疗后踝肱指数改善的临床影响。
Heart Vessels. 2020 Feb;35(2):177-186. doi: 10.1007/s00380-019-01485-z. Epub 2019 Aug 23.
8
Perfusion Assessment in Critical Limb Ischemia: Principles for Understanding and the Development of Evidence and Evaluation of Devices: A Scientific Statement From the American Heart Association.严重肢体缺血的灌注评估:理解原则、证据开发和设备评估:美国心脏协会的科学声明。
Circulation. 2019 Sep 17;140(12):e657-e672. doi: 10.1161/CIR.0000000000000708. Epub 2019 Aug 12.
9
A systematic review of the use of near-infrared fluorescence imaging in patients with peripheral artery disease.应用近红外荧光成像技术治疗外周动脉疾病的系统评价。
J Vasc Surg. 2019 Jul;70(1):286-297.e1. doi: 10.1016/j.jvs.2018.11.023.
10
Global vascular guidelines on the management of chronic limb-threatening ischemia.全球血管指南:慢性肢体威胁性缺血的管理。
J Vasc Surg. 2019 Jun;69(6S):3S-125S.e40. doi: 10.1016/j.jvs.2019.02.016. Epub 2019 May 28.